Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
01/17/2025 | CALL | $97.50 | 3,258 | +1,049 | +47.49% |
01/17/2025 | CALL | $88.00 | 4,371 | +931 | +27.06% |
01/17/2025 | CALL | $90.00 | 2,135 | +728 | +51.74% |
06/20/2025 | CALL | $100.00 | 1,186 | +74 | +6.65% |
01/17/2025 | CALL | $84.00 | 204 | +70 | +52.24% |
01/17/2025 | PUT | $73.00 | 81 | +43 | +113.16% |
01/10/2025 | CALL | $81.00 | 458 | -16 | -3.38% |
03/21/2025 | PUT | $95.00 | 102 | -19 | -15.70% |
01/10/2025 | PUT | $78.00 | 100 | -27 | -21.26% |
06/20/2025 | CALL | $80.00 | 1,477 | -34 | -2.25% |
01/17/2025 | CALL | $85.00 | 8,236 | -251 | -2.96% |
01/17/2025 | CALL | $80.00 | 11,006 | -266 | -2.36% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.03% | 11.75M | 1.57B |
Vanguard Mid-Cap Index Fund | 2.32% | 8.99M | 1.2B |
Vanguard 500 Index Fund | 2.30% | 8.93M | 1.19B |
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 5.08M | 679.14M |
Fidelity 500 Index Fund | 1.09% | 4.23M | 566.01M |
SPDR S&P 500 ETF Trust | 1.08% | 4.17M | 558.06M |
College Retirement Equities Fund-Growth Account | 0.89% | 3.46M | 461.99M |
iShares Core S&P 500 ETF | 0.89% | 3.45M | 460.81M |
Growth Fund Of America Inc | 0.87% | 3.36M | 449.71M |
Vanguard Growth Index Fund | 0.84% | 3.26M | 435.8M |
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
01/08 09:30 am
The Motley Fool
Read moreRethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
01/07 11:00 am
GlobeNewswire Inc.
Read moreThese Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
01/04 08:45 am
The Motley Fool
Read more1 Reason to Sell DexCom Stock, and 1 Reason to Buy
12/21 07:45 am
The Motley Fool
Read more3 Reasons to Buy DexCom Stock Like There's No Tomorrow
12/02 10:12 am
The Motley Fool
Read more2 Excellent Healthcare Stocks to Hold Through the Next Decade
11/28 08:45 am
The Motley Fool
Read moreThese Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
11/26 08:30 am
The Motley Fool
Read moreWearable Patch Market to Expand at a High 7.9% CAGR through 2031 | SkyQuest Technology
11/25 06:10 am
Benzinga
Read more2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
11/24 11:15 am
The Motley Fool
Read more1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
11/08 11:15 am
The Motley Fool
Read moreTive Announces Inaugural Winners of the Green Impact Award: Celebrating Environmental Stewardship in Supply Chain Management
10/29 09:00 am
GlobeNewswire Inc.
Read moreConnected Healthcare Devices Market to hit USD 240 billion by 2032, says Global Market Insights Inc.
10/28 06:38 am
GlobeNewswire Inc.
Read moreWhy DexCom Stock Flopped on Friday
10/25 05:53 pm
The Motley Fool
Read moreDXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
10/20 05:54 pm
GlobeNewswire Inc.
Read moreDXCM DEADLINE ALERT: DexCom, Inc. Investors are Notified of Imminent Monday October 21 Legal Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)
10/19 06:31 am
GlobeNewswire Inc.
Read moreWhere Will DexCom Be in 5 Years?
10/18 08:00 am
The Motley Fool
Read moreIs Abbott Laboratories Stock a Buy?
10/17 07:30 am
The Motley Fool
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
10/16 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING TRIAL ATTORNEYS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
10/13 12:05 pm
GlobeNewswire Inc.
Read more2 Magnificent Stocks to Buy That Are Near 52-Week Lows
10/12 11:40 am
The Motley Fool
Read moreDexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
10/12 11:15 am
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
10/10 08:36 pm
GlobeNewswire Inc.
Read moreDXCM FRAUD NEWS: October 21 Class Action Deadline is Approaching; DexCom, Inc. Investors that Lost Money are Notified to Contact BFA Law (Nasdaq:DXCM)
10/09 06:47 am
GlobeNewswire Inc.
Read moreDEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
10/07 03:01 pm
GlobeNewswire Inc.
Read moreROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
10/06 06:34 am
GlobeNewswire Inc.
Read more2 Beaten-Down Growth Stocks You Might Regret Not Buying
10/05 06:45 am
The Motley Fool
Read moreDXCM LITIGATION ALERT: DexCom, Inc. Investors are Notified to Contact BFA Law before Imminent October 21 Deadline in Securities Fraud Class Action (Nasdaq:DXCM)
10/05 06:43 am
GlobeNewswire Inc.
Read moreIs DexCom a Millionaire Maker?
10/05 05:43 am
The Motley Fool
Read moreDXCM Deadline Approaching on October 21, 2024: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Class Action Lawsuit Deadline
10/04 09:31 am
GlobeNewswire Inc.
Read moreROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
10/03 08:50 pm
GlobeNewswire Inc.
Read moreDXCM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
10/03 05:40 pm
GlobeNewswire Inc.
Read moreDown More Than 50%, Is DexCom Stock a Bargain Now?
10/02 04:11 am
The Motley Fool
Read moreROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
09/30 06:48 pm
GlobeNewswire Inc.
Read moreDexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook- Hagens Berman
09/30 03:29 pm
GlobeNewswire Inc.
Read moreGlobal Chronic Disease Management Market Size to Reach USD 17.28 Billion by 2033 | Witnessing a CAGR of 12.80%
09/30 02:40 pm
GlobeNewswire Inc.
Read more2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
09/30 07:15 am
The Motley Fool
Read moreDXCM STOCK UPDATE: Investors of DexCom, Inc. are Alerted of Imminent October 21 Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)
09/29 06:31 am
GlobeNewswire Inc.
Read moreDXCM ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against DexCom, Inc.
09/26 08:32 pm
GlobeNewswire Inc.
Read moreKirby McInerney LLP Notifies Investors of Lead Plaintiff Deadline in Dexcom Inc. (DXCM) Securities Class Action
09/26 04:28 pm
GlobeNewswire Inc.
Read moreDexCom Is Great. Here's Why You Shouldn't Buy It.
09/25 09:45 am
The Motley Fool
Read moreIs DexCom a Millionaire Maker?
09/25 08:07 am
The Motley Fool
Read moreROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
09/24 08:03 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
09/24 01:43 pm
GlobeNewswire Inc.
Read moreDexCom (DXCM) Blamed Disruptive Sales Force Changes For Its Disappointing Q2 2024 Results And Outlook, Resulting In 40% Stock Drop And Class Action - Hagens Berman
09/23 03:51 pm
GlobeNewswire Inc.
Read moreROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
09/21 09:30 am
GlobeNewswire Inc.
Read more